SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-067413
Filing Date
2020-03-10
Accepted
2020-03-09 18:53:03
Documents
5
Period of Report
2020-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d830480d8k.htm 8-K 23334
2 EX-5.1 d830480dex51.htm EX-5.1 20731
3 EX-10.1 d830480dex101.htm EX-10.1 13755
4 GRAPHIC g830480g65s80.jpg GRAPHIC 10510
5 GRAPHIC g830480g90q39.jpg GRAPHIC 9303
  Complete submission text file 0001193125-20-067413.txt   75685
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 20699357
SIC: 3841 Surgical & Medical Instruments & Apparatus